Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina Inc (NQ: ILMN )

143.82 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina Inc

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
29 30 Next >
A Look Into Illumina's Debt
Via Benzinga
How Is The Market Feeling About Illumina?
Via Benzinga
Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States
Strategic partnership offers a unique combination of diagnostic development and commercialization capabilities to the pharmaceutical industry 
From Myriad Genetics, Inc.
Via GlobeNewswire
The Next Generation Of Cancer Vaccines Are Coming; What That Means For Moderna And Other Biotech Stocks
Startling cancer vaccine results from Moderna may point to the next big thing in biotech. 
Via Investor's Business Daily
DNA-Reading Giant Illumina Topples On Wide Profit Miss
Sales narrowly topped expectations, however. 
Via Investor's Business Daily
If You Invested $100 In This Stock 10 Years Ago, You Would Have $400 Today
Via Benzinga
Earnings Preview For Illumina
Via Benzinga
7 Analysts Have This to Say About Illumina
Via Benzinga
Home Healthcare Equipment Market Trends, Volume, Growth Strategies Forecast Report 2023
Some of the major players profiled in the Home Healthcare Equipment Market report are Abbott Laboratories (US), F. Hoffman-La Roche (Switzerland), QIAGEN (Germany), Thermo Fisher Scientific (US),... 
Via SBWire
Topics Economy
Exposures Supply Chain
Cri-Du-Chat Syndrome Market Demand Trends Size Overview Analysis 2022-2029
Global Cri-du-chat Syndrome Market to Witness Huge Growth by Key Players: Centogene AG, Eurofins Scientific, Laboratory Corporation of America Holdings, Quest Diagnostics, PerkinElmer Inc., Natera,... 
Via SBWire
7 Stocks to Buy and Hold for the Next 20 Years
When choosing stocks to buy and hold for the next 20 years, pick companies with strong comparative advantages in durable sectors. 
Via InvestorPlace
Cramer Likens This Stock To 'A Fine Merlot': It's Down 1% In 2023, So 'I Would Buy All You Can Right Here'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Parker-Hannifin Corp (NYSE: PH) is "just the kind of industrial I’ve been recommending." 
Via Benzinga
Illumina's Woes Mount As Guidance Lags And Grail Controversy Continues
Illumina projected far lighter-than-expected profit guidance for 2023. 
Via Investor's Business Daily
Is Illumina Cheap or Expensive?
It depends on which numbers you focus on. 
Via The Motley Fool
What 7 Analyst Ratings Have To Say About Illumina
Via Benzinga
New Survey Data Shows Innovation Teams at Large Companies Are Focusing More on Near-Term Initiatives, but Internal Politics and Culture Remain Top Challenges
InnoLead has released a 2023 update to its popular Benchmarking Innovation Impact research with KPMG LLP. 
Via Newswire.com
US Stocks Pause Ahead Of Powell's Speech: Analyst Warns Of Retest Of October Lows As Market, Economic Data Conspire Against Monetary Policy
Stocks look set for another nervous session on Tuesday as traders look ahead to comments from Fed Chair Jerome Powell and another batch of earnings reports. Cues From Monday’s Trading: 
Via Benzinga
Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover
Danaher is reportedly looking to add to its wheelhouse to compete with Thermo. 
Via Investor's Business Daily
Healthcare Sector Is Lagging As We Enter 2022 Earnings Season
The healthcare sector is perceived as defensive but in 2023 there is more investor appetite for risk based on the QQQ comeback and the XBI strength. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For January 25, 2023
Via Benzinga
Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review
Sharp Tesla price cuts and some notable earnings were in focus. 
Via Investor's Business Daily
Universal Sequencing Technology Corporation (UST) partners with TATAA Biocenter to offer Long Read Sequencing Services with TELL-Seq Linked-Read Tech
CARLSBAD, Calif. - Jan. 10, 2023 - PRLog -- Universal Sequencing Technology Corporation (UST) announces today, January 10th, 2022, that it has partnered with TATAA Biocenter, one of our key... 
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property
Illumina Shares Tank After Annual Guidance Fall Short Of Expectations
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
US Stocks Show Tentativeness On Tuesday As Traders Wait On Word From Fed Chair Jerome Powell
U.S. stocks look set to start Tuesday’s session on a nervous note as traders may prefer to wait and watch the inflation data before making their next moves. 
Via Benzinga
QIAGEN Acquires Verogen Strengthening Its Position In Human ID / Forensics
Via Benzinga
What Does Illumina's Debt Look Like?
Shares of Illumina Inc. (NASDAQ:ILMN) moved higher by 1.43% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.